BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16579822)

  • 1. Strengthening the case for disease management effectiveness: un-hiding the hidden bias.
    Linden A; Adams JL; Roberts N
    J Eval Clin Pract; 2006 Apr; 12(2):140-7. PubMed ID: 16579822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving participant selection in disease management programmes: insights gained from propensity score stratification.
    Linden A; Adams JL
    J Eval Clin Pract; 2008 Oct; 14(5):914-8. PubMed ID: 19018926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does analysis using "last observation carried forward" introduce bias in dementia research?
    Molnar FJ; Hutton B; Fergusson D
    CMAJ; 2008 Oct; 179(8):751-3. PubMed ID: 18838445
    [No Abstract]   [Full Text] [Related]  

  • 6. A new u-statistic with superior design sensitivity in matched observational studies.
    Rosenbaum PR
    Biometrics; 2011 Sep; 67(3):1017-27. PubMed ID: 21175557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on randomization and selection bias in maintenance therapy clinical trials.
    Greenhouse JB; Meyer MM
    Psychopharmacol Bull; 1991; 27(3):225-9. PubMed ID: 1775592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
    Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, confounding, and the illusion of statistical control.
    Christenfeld NJ; Sloan RP; Carroll D; Greenland S
    Psychosom Med; 2004; 66(6):868-75. PubMed ID: 15564351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating disease management programme effectiveness: an introduction to the regression discontinuity design.
    Linden A; Adams JL; Roberts N
    J Eval Clin Pract; 2006 Apr; 12(2):124-31. PubMed ID: 16579820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical issues in longitudinal and observational studies: purpose, short versus long term, selection of study instruments, methods, outcomes, and biases.
    Wolfe F
    J Rheumatol; 1999 Feb; 26(2):469-72. PubMed ID: 9972989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 16. A potential bias in safety evaluation during open-label extensions of randomized clinical trials.
    Rothman KJ
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):295-8. PubMed ID: 15133780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster randomized controlled trials in primary care: an introduction.
    Murphy AW; Esterman A; Pilotto LS
    Eur J Gen Pract; 2006; 12(2):70-3. PubMed ID: 16945880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating disease management programme effectiveness: an introduction to instrumental variables.
    Linden A; Adams JL
    J Eval Clin Pract; 2006 Apr; 12(2):148-54. PubMed ID: 16579823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analysis for matched case-control studies.
    Rosenbaum PR
    Biometrics; 1991 Mar; 47(1):87-100. PubMed ID: 2049516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.